Company Analysis

Kestra Medical Technologies, Ltd. (KMTS)

Nasdaq: KMTS · Surgical & Medical Instruments & Apparatus · Kirkland, WA · filing with the SEC since 2021
Grade5.8
◀ Past 6.4● Present 5.5▶ Future 5.6
3 est.
The companyfiscal 2026, as filed
Revenue$95.1M+59.0%
Net income-$132M-15.6%
Earnings per share$-2.43+52.6%
Operating cash flow-$81.7M-5.3%
Cash$100M-58.0%
Debt$42.6M+3.8%
Shareholders’ equity$260M+26.4%
Shares, diluted54.2M+120.4%
Return on equity-50.7%
The recordfrom its filings
Filings in 2026102
Newest filingNov 5 · 4
Annual reportJul 14, 2026
Quarterly reportSep 14, 2026
Next report due10-Q by Dec 15
Insider sales, 12 months$15.5M
Insider buys, 12 months$200,000
Patents granted101
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Trailing twelve months to Jul 2026Revenue $107MNet income -$150MCash from operations -$87.7Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
242526
As filed, in USD. Nothing here is a forecast.

News

Nov 5, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Oct 29, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Oct 29, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Oct 22, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Oct 22, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton KMTS · research, not advice